SCHEMBL29779999

SCHEMBL29779999

CC(=O)N(c1cc[nH]n1)C1CCSC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ RAB9A P51151 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ PKM P14618 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ APAF1 O14727 1/20 0.32
▸ TDP2 O95551 1/20 0.32
▸ S1PR4 O95977 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ XBP1 P17861 1/20 0.32
▸ S1PR1 P21453 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CACNA1B Q00975 1/20 0.32
▸ APBA1 Q02410 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20777281 0.80 TRPM8 (0.45) DRD4LMNARAB9AKDM4ENPC1
SCHEMBL20777380 0.79 TRPM8 (0.45) LMNAALDH1A1MAPTL3MBTL1
SCHEMBL20777357 0.79 TRPM8 (0.54) LMNARAB9ANPC1ALDH1A1MAPT
SCHEMBL20777379 0.78 TRPM8 (0.49) LMNARAB9AKDM4ENPC1ALDH1A1
SCHEMBL30579627 0.78 TRPM8 (0.51) LMNARAB9AKDM4ENPC1ALDH1A1
SCHEMBL20777361 0.78 TRPM8 (0.51) LMNARAB9AKDM4ENPC1ALDH1A1
SCHEMBL20777320 0.78 MEN1 (0.46) LMNARAB9AKDM4ENPC1ALDH1A1
SCHEMBL29780007 0.78 MEN1 (0.46) LMNARAB9AKDM4ENPC1ALDH1A1
SCHEMBL20777284 0.77 MAPT (0.42) LMNARAB9AKDM4ENPC1ALDH1A1
SCHEMBL20777359 0.77 TRPM8 (0.54) LMNAKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients BASF SE (DE) 2022-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients TRPM8, TRPM7, TRPM5 DRD4 3920/4885LMNA 1495/4885RAB9A 3290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback